EIGR


Billionaire David Shaw Pours Money Into 3 “Strong Buy” Stocks

Are the tides turning on Wall Street? Stocks fell for a third consecutive session, as investors abandoned the tech heavyweights that have been …

2 Notable Biotech Calls

It has not been a good day for investors this Thursday.  Worries about trade, the situation in Saudi Arabia, plunging oil prices, falling …

Eiger (EIGR) Successfully Licensed Rights to Progeria; Wedbush Boosts Price Target

Many investors hope to win big on biotech stocks as shares can skyrocket when there’s good news. Case in point: Eiger Biopharmaceuticals (NASDAQ:EIGR) …

Oppenheimer Slashes Price Target on Eiger Biopharmaceuticals Inc (EIGR) Following Clinical Failure in PAH, But Remains Bullish

The company’s future is in serious doubt, but it doesn’t prevent Oppenheimer’s Jay Olson from hitting the ‘buy’ button.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts